ACM
AIGH Capital Management Portfolio holdings
AUM
$213M
This Quarter Return
-10.36%
1 Year Return
+95.37%
3 Year Return
+329.16%
5 Year Return
–
10 Year Return
–
AUM
$193M
AUM Growth
+$193M
(-27%)
Cap. Flow
-$22.5M
Cap. Flow
% of AUM
-11.68%
Top 10 Holdings %
Top 10 Hldgs %
57.13%
Holding
48
New
10
Increased
8
Reduced
18
Closed
8
Top Buys
| 1 |
Vishay Precision Group
VPG
|
$6.35M |
| 2 |
Heron Therapeutics
HRTX
|
$6.11M |
| 3 |
Domo
DOMO
|
$5.83M |
| 4 |
Akebia Therapeutics
AKBA
|
$5.62M |
| 5 |
Zevra Therapeutics
ZVRA
|
$4.86M |
Top Sells
| 1 |
Marvell Technology
MRVL
|
$16.6M |
| 2 |
Delcath Systems
DCTH
|
$14.3M |
| 3 |
Tarsus Pharmaceuticals
TARS
|
$12.4M |
| 4 |
Xeris Biopharma Holdings
XERS
|
$8.73M |
| 5 |
Corning
GLW
|
$3.56M |
Sector Composition
| 1 | Healthcare | 63.74% |
| 2 | Technology | 25.34% |
| 3 | Industrials | 10.92% |
| 4 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Verastem
VSTM
$569M
| $14.1M | 5.84% | 2,337,754 -327,289 | -12% | -$1.97M |
|
2
Myomo
MYO
$39.7M
| $14M | 5.79% | 2,906,689 -474,878 | -14% | -$2.28M |
|
3
Personalis
PSNL
$434M
| $13.9M | 5.77% | 3,968,948 +169,884 | +4% | +$596K |
|
4
Arq
ARQ
$330M
| $11.6M | 4.78% | 2,770,278 -46,800 | -2% | -$195K |
|
5
scPharmaceuticals
SCPH
$295M
| $10.8M | 4.46% | 4,096,367 -78,000 | -2% | -$205K |
|
|
6
Zevra Therapeutics
ZVRA
$509M
| $10.8M | 4.46% | 1,438,109 +649,495 | +82% | +$4.86M |
|
7
BK Technologies
BKTI
$264M
| $10.5M | 4.35% | 268,180 | – | – |
|
8
Elutia
ELUT
$96.7M
| $8.55M | 3.54% | 3,381,415 +306,740 | +10% | +$776K |
|
9
Backblaze
BLZE
$471M
| $8.27M | 3.42% | 1,712,321 -87,679 | -5% | -$423K |
|
10
Coya Therapeutics
COYA
$110M
| $7.66M | 3.17% | 1,183,780 -17,372 | -1% | -$112K |
|
11
Lightpath Technologies
LPTH
$230M
| $7.4M | 3.06% | 3,682,932 -41,000 | -1% | -$82.4K |
|
|
12
Vishay Precision Group
VPG
$377M
| $6.35M | 2.63% | +263,565 | New | +$6.35M |
|
|
13
Heron Therapeutics
HRTX
$207M
| $6.11M | 2.53% | +2,778,200 | New | +$6.11M |
|
|
14
Domo
DOMO
$591M
| $5.83M | 2.41% | +751,583 | New | +$5.83M |
|
|
15
Akebia Therapeutics
AKBA
$833M
| $5.62M | 2.32% | +2,925,000 | New | +$5.62M |
|
|
ELVA
16
Electrovaya
ELVA
$243M
| $5.24M | 2.17% | 2,262,323 -262,776 | -10% | -$609K |
|
17
Intellicheck
IDN
$109M
| $4.84M | 2% | 1,597,538 -20,158 | -1% | -$61.1K |
|
18
AngioDynamics
ANGO
$417M
| $4.46M | 1.84% | +474,488 | New | +$4.46M |
|
19
Ideal Power
IPWR
$44.5M
| $4.26M | 1.76% | 818,315 -5,000 | -0.6% | -$26K |
|
20
RenovoRx
RNXT
$35.2M
| $3.43M | 1.42% | +3,467,275 | New | +$3.43M |
|
|
21
Delcath Systems
DCTH
$385M
| $3.32M | 1.37% | 260,719 -1,124,670 | -81% | -$14.3M |
|
|
THTX
22
Theratechnologies
THTX
$149M
| $3.26M | 1.35% | 2,326,569 -700,000 | -23% | -$980K |
|
|
GRCE
23
Grace Therapeutics, Inc. Common Stock
GRCE
$41.9M
| $3.02M | 1.25% | 1,322,379 +801,296 | +154% | +$1.83M |
|
24
Biodesix
BDSX
$62.6M
| $2.67M | 1.11% | 4,272,591 -1,907,221 | -31% | -$1.19M |
|
25
PolyPid
PYPD
$53.3M
| $2.55M | 1.06% | 940,381 +112,514 | +14% | +$305K |
|